150 related articles for article (PubMed ID: 2384651)
21. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
23. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
Kamada AK; Hill MR; Brenner AM; Szefler SJ
Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].
Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R
Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481
[TBL] [Abstract][Full Text] [Related]
25. [Initial experiences with "Oranienburg" slow-release theophylline in asthma therapy of children and adolescents].
Sollich V; Schuster R; Thal W; Köhler E; Walther H
Kinderarztl Prax; 1990 Jan; 58(1):45-8. PubMed ID: 2332947
[TBL] [Abstract][Full Text] [Related]
26. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA
Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
Kelly HW; Murphy S
Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
[TBL] [Abstract][Full Text] [Related]
28. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
[TBL] [Abstract][Full Text] [Related]
29. [The monitoring of delayed-release theophylline therapy in bronchial asthma in children by determining the salivary concentration].
Panta P; Nanulescu MV; Culea M; Palibroda N
Pneumoftiziologia; 1998; 47(1):15-9. PubMed ID: 9932029
[TBL] [Abstract][Full Text] [Related]
30. [Posture and circadian variations in serum theophylline concentrations].
Kishida M; Hukushima K; Iikura Y
Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
[TBL] [Abstract][Full Text] [Related]
31. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
32. [Continuous treatment of asthma in children with theophylline retard].
de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
[TBL] [Abstract][Full Text] [Related]
33. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
Trnavská Z; Rejholec V; Elis J; Spicák V
Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
[TBL] [Abstract][Full Text] [Related]
35. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
[TBL] [Abstract][Full Text] [Related]
36. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
38. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Schaefers M; Richter O; Reinhardt D; Becker B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
[TBL] [Abstract][Full Text] [Related]
39. Individualization of theophylline dosage using a single serum sample following a test dose.
Shapiro GG; Koup JR; Furukawa CT; Pierson WE; Gibaldi M; Fuquay D; Bierman CW
Pediatrics; 1982 Jan; 69(1):70-3. PubMed ID: 7054763
[TBL] [Abstract][Full Text] [Related]
40. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
